Literature DB >> 3265101

A comparison of Tc-99m HM-PAO and I-123 IMP cerebral SPECT images in Alzheimer's disease and multi-infarct dementia.

H G Gemmell1, P F Sharp, J A Besson, K P Ebmeier, F W Smith.   

Abstract

SPECT images of the brain can be obtained using either 123I labelled amines or 99mTc-hexamethylpropyleneamineoxime (HM-PAO). Both materials produce images which are blood flow dominated and so appear similar in normal subjects, although the respective mechanisms of uptake are not yet finally established. It seems likely, however, that the different mechanisms of uptake are responsible for recent reports of some differences seen in images obtained with the two types of agent in patients with cerebral pathology, mainly cerebrovascular disease. In this study, 12 demented patients, 6 with dementia of the Alzheimer type (DAT) and 6 with multi infarct dementia (MID), were imaged with 123I-isopropylamphetamine (IMP) and 99mTc-HM-PAO and the images compared. Significantly more lesions were seen with IMP than HM-PAO (P less than 0.02); out of a possible 120 sites, 41 lesions were seen with IMP compared to 28 with HM-PAO, 23 being seen with both agents. However, it is concluded that either agent can be used for the differential diagnosis of dementia, a task for which the new cerebral blood flow agents seem well suited.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265101     DOI: 10.1007/bf00252389

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  18 in total

1.  Single photon emission tomography with 123I-isopropylamphetamine in Alzheimer's disease and multi-infarct dementia.

Authors:  H G Gemmell; P F Sharp; N T Evans; J A Besson; D Lyall; F W Smith
Journal:  Lancet       Date:  1984-12-08       Impact factor: 79.321

2.  The interfacing of a gamma camera to a DEC Gamma-11 data processing system for single-photon emission tomography.

Authors:  R Chesser; H Gemmell
Journal:  Phys Med Biol       Date:  1982-03       Impact factor: 3.609

3.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

4.  Cerebral blood flow studies with 123iodine-labelled amines.

Authors:  P J Ell; D Lui; I Cullum; P H Jarritt; M Donaghy; M J Harrison
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

5.  Initial experience with SPECT of the brain using 99mTc-hexamethyl-propyleneamine oxime (99mTc-HM-PAO).

Authors:  G Spreafico; F Cammelli; G Gadola; G Nicola; F Zancaner; G Tonnarelli; E Sala; R Freschi
Journal:  Eur J Nucl Med       Date:  1987

6.  Technetium-99m-d, 1-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT--a comparison with iodine-123 HIPDM.

Authors:  J P Leonard; D P Nowotnik; R D Neirinckx
Journal:  J Nucl Med       Date:  1986-12       Impact factor: 10.057

7.  Differential diagnosis in dementia using the cerebral blood flow agent 99mTc HM-PAO: a SPECT study.

Authors:  H G Gemmell; P F Sharp; J A Besson; J R Crawford; K P Ebmeier; J Davidson; F W Smith
Journal:  J Comput Assist Tomogr       Date:  1987 May-Jun       Impact factor: 1.826

8.  Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion.

Authors:  R D Neirinckx; L R Canning; I M Piper; D P Nowotnik; R D Pickett; R A Holmes; W A Volkert; A M Forster; P S Weisner; J A Marriott
Journal:  J Nucl Med       Date:  1987-02       Impact factor: 10.057

9.  Cerebral dynamics of N-isopropyl-(123I)p-iodoamphetamine.

Authors:  H Creutzig; O Schober; P Gielow; R Friedrich; H Becker; H Dietz; H Hundeshagen
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

10.  Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies.

Authors:  P F Sharp; F W Smith; H G Gemmell; D Lyall; N T Evans; D Gvozdanovic; J Davidson; D A Tyrrell; R D Pickett; R D Neirinckx
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

View more
  9 in total

1.  Demonstration of decreased posterior cingulate perfusion in mild Alzheimer's disease by means of H215O positron emission tomography.

Authors:  K Ishii; M Sasaki; S Yamaji; S Sakamoto; H Kitagaki; E Mori
Journal:  Eur J Nucl Med       Date:  1997-06

2.  Semi-quantitative analysis of regional cerebral perfusion.

Authors:  H G Gemmell; P F Sharp
Journal:  Eur J Nucl Med       Date:  1989

3.  Hereditary cerebral hemorrhage with amyloidosis--Dutch type. Tc-99m HM-PAO single photon emission computed tomography.

Authors:  J Haan; M J van Kroonenburgh; P R Algra; O J Buruma; E K Pauwels; B R Bloem; R A Roos
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

4.  Comparison of I-123 IMP and Tc-99m HMPAO SPECT studies with PET in dementia.

Authors:  Y Kuwabara; Y Ichiya; M Otsuka; T Tahara; T Fukumura; R Gunasekera; A Ichimiya; K Masuda
Journal:  Ann Nucl Med       Date:  1990-11       Impact factor: 2.668

5.  Artificial neural networks that use single-photon emission tomography to identify patients with probable Alzheimer's disease.

Authors:  M R Dawson; A Dobbs; H R Hooper; A J McEwan; J Triscott; J Cooney
Journal:  Eur J Nucl Med       Date:  1994-12

Review 6.  Diagnostic and pharmacological approaches in Alzheimer's disease.

Authors:  C Hermann; R G Stern; M F Losonzcy; S Jaff; M Davidson
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

7.  99mTc-HMPAO-SPECT in the diagnosis of senile dementia of Alzheimer's type--a study under clinical routine conditions.

Authors:  G Stoppe; J Staedt; A Kögler; R Schütze; H J Kunert; D Sandrock; D L Munz; D Emrich; E Rüther
Journal:  J Neural Transm Gen Sect       Date:  1995

8.  HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.

Authors:  R Mielke; U Pietrzyk; A Jacobs; G R Fink; A Ichimiya; J Kessler; K Herholz; W D Heiss
Journal:  Eur J Nucl Med       Date:  1994-10

9.  Neuropsychological tests and [99mTc]-HM PAO SPECT in the diagnosis of Alzheimer's dementia.

Authors:  G Villa; A Cappa; M Tavolozza; G Gainotti; A Giordano; M L Calcagni; G De Rossi
Journal:  J Neurol       Date:  1995-06       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.